Strand is a company founded by biological engineers from MIT that has created the world's first platform for mRNA smart therapies. They have developed an mRNA "programming language" that allows for the precise control of therapeutic protein expression inside a patient's body using mRNA-encoded logic circuits. This technology promises to make mRNA therapies safer and more effective by implementing cell-type specific expression and controlling protein dosage.